RTT107 Antibody

What is RTT107 and why are antibodies against it valuable for research?

RTT107 (also known as Esc4 in budding yeast) is a conserved scaffold protein containing six BRCT domains that support multiple protein-protein interactions . RTT107 antibodies are essential tools for investigating its role in genome maintenance, as this protein forms distinct complexes with at least three key partners: the Rtt101 cullin ubiquitin ligase complex, the Smc5/6 SUMO ligase complex, and the scaffold protein Slx4 .

For effective research applications, RTT107 antibodies should be validated through multiple approaches:

• Western blot verification against wild-type and rtt107Δ samples

• Immunoprecipitation efficiency testing

• Epitope accessibility assessment in different experimental conditions

• Cross-reactivity testing against related BRCT domain-containing proteins

The most valuable antibodies recognize regions that don't interfere with RTT107's critical protein-protein interaction domains while maintaining high specificity and sensitivity.

What experimental techniques commonly employ RTT107 antibodies?

RTT107 antibodies facilitate several key techniques in genome maintenance research:

When performing co-immunoprecipitation experiments, researchers should consider that RTT107 forms three distinct complexes rather than a single mega-complex . This necessitates careful experimental design to distinguish between these separate interaction networks.

How can RTT107 antibodies help investigate protein-protein interactions in genome maintenance?

RTT107 antibodies are instrumental in dissecting the complex interaction network of this scaffold protein. Research demonstrates that RTT107 independently interacts with its three major partners (Rtt101-Mms22 complex, Smc5/6 complex, and Slx4), as these interactions persist even when one partner is absent .

To effectively map these interactions:

• Perform bidirectional co-immunoprecipitation experiments using both RTT107 antibodies and antibodies against suspected binding partners

• Include appropriate controls with single gene deletions to verify independent interactions

• Test interactions under both normal conditions and after DNA damage induction (e.g., MMS treatment)

• Supplement antibody-based approaches with yeast two-hybrid assays for direct interaction verification

• Consider crosslinking approaches to capture transient interactions

Recent studies using these approaches have revealed that RTT107 also directly interacts with replisome components including Pol2, Mcm6, and Mrc1, providing insight into its role in DNA replication .

How can researchers use RTT107 antibodies to differentiate between its distinct complex formations?

Distinguishing between RTT107's three distinct complexes requires sophisticated immunoprecipitation approaches:

• Sequential immunoprecipitation: First precipitate RTT107 using specific antibodies, then perform a second immunoprecipitation using antibodies against each suspected partner. This approach can isolate specific subcomplexes.

• Competitive binding experiments: Pre-incubate samples with peptides representing specific RTT107-interaction domains to selectively block certain complexes before immunoprecipitation.

• Size exclusion chromatography followed by immunoblotting: This can separate complexes by molecular weight before detection with RTT107 antibodies.

• Native gel electrophoresis: Combined with antibody detection, this can preserve and distinguish between intact protein complexes.

Research demonstrates that while Rtt107 co-purifies with Mms22 both with and without MMS treatment, Smc5 does not co-purify with Mms22 . Similarly, Rtt107 associates with Slx4, but Smc5 does not . These findings support the existence of distinct complexes rather than a single mega-complex containing all partners.

What methodological approaches can resolve conflicting data when studying RTT107 interactions?

When researchers encounter contradictory results regarding RTT107 interactions, several methodological approaches can help resolve these conflicts:

• Varied extraction conditions: Different buffer compositions can significantly affect complex stability. Systematically test various salt concentrations, detergents, and stabilizing agents.

• Domain-specific antibodies: Generate antibodies against specific domains of RTT107 to determine if certain interactions are masked by conformational changes or competing interactions.

• Controlled expression systems: Use inducible expression systems to control protein levels and avoid artifacts from overexpression.

• Phosphorylation state analysis: Since RTT107 interactions can be phosphorylation-dependent, use phosphorylation-specific antibodies or phosphatase treatments to determine if modifications affect interaction patterns.

• Mass spectrometry validation: Combine immunoprecipitation with mass spectrometry to identify all proteins in a complex without relying solely on antibody detection.

For example, research has shown that the interaction between RTT107 and Rad55-Rad57 is largely disrupted by a rad55-S404A phosphorylation site mutation , demonstrating how phosphorylation states can critically affect interaction detection.

How can RTT107 antibodies be used to investigate replication fork progression?

RTT107 antibodies are valuable tools for studying replication progression, particularly given RTT107's role in supporting replication in distal regions of large replicons . Methodological approaches include:

• Chromatin immunoprecipitation followed by sequencing (ChIP-seq): This technique can map RTT107 localization along replicating chromosomes. Key considerations include:

  • Crosslinking optimization to capture transient interactions

  • Use of replication synchronization methods (e.g., α-factor arrest and release)

  • Sequential ChIP to determine co-localization with replisome components

• Proximity ligation assays: These can detect RTT107 interactions with specific replisome components in situ, revealing spatial and temporal dynamics.

• Immunoprecipitation combined with replication fork analysis:

  • Pull down RTT107-associated complexes and analyze associated nascent DNA

  • Combine with electron microscopy to visualize replication fork structures

• SUMO-modified protein analysis:

  • Use RTT107 antibodies alongside SUMO-specific antibodies to investigate RTT107's role in promoting sumoylation of replisome components

  • Implement a dual-immunoprecipitation approach to isolate specifically sumoylated replisome proteins that associate with RTT107

These approaches can help elucidate how RTT107 supports replication progression, particularly in challenging genomic regions.

What considerations should be made when using epitope-tagged RTT107 versus antibodies against the native protein?

Researchers often use epitope-tagged versions of RTT107 (as seen in the studies cited ), but this approach introduces important considerations:

Critical validation experiments include:

• Complementation testing: Verify that tagged RTT107 rescues rtt107Δ phenotypes

• Interaction verification: Confirm that tagged RTT107 maintains all known protein interactions

• Localization comparison: Compare subcellular distribution of tagged versus native protein

• Growth and damage sensitivity testing: Ensure tagged strains respond normally to replication stress

How can RTT107 antibodies be used to investigate its role in preventing genome instability?

RTT107 plays a crucial role in preventing genome instability, particularly loss of heterozygosity (LOH) and crossover events . RTT107 antibodies can be employed to investigate these functions through several approaches:

• Chromatin immunoprecipitation at recombination hotspots:

  • Map RTT107 localization at known recombination sites

  • Compare binding patterns between wild-type cells and recombination-prone mutants

  • Analyze co-occupancy with recombination mediators like Rad55-Rad57

• Co-immunoprecipitation studies with recombination factors:

  • Investigate interactions between RTT107 and Rad55-Rad57 under various conditions

  • Determine how these interactions are affected by phosphorylation states

  • Assess how complex formation changes during recombination events

• Immunoprecipitation-based analysis of crossover intermediates:

  • Use RTT107 antibodies to pull down DNA structures at different stages of recombination

  • Combine with electron microscopy to visualize recombination intermediates

Research has demonstrated that RTT107 acts in the same pathway as Rad55 to limit LOH specifically by preventing crossover events, and this function depends on the phosphorylation state of Rad55-S404 . This highlights the importance of phosphorylation-sensitive detection methods when studying RTT107's recombination-related functions.

What technical challenges exist in detecting phosphorylation-dependent interactions of RTT107?

Studying phosphorylation-dependent interactions of RTT107 presents several technical challenges:

• Phosphorylation site specificity:

  • The Rad55-S404 phosphorylation site significantly affects RTT107 interaction

  • Researchers should generate phospho-specific antibodies for key sites

  • Consider using phosphorylation-mimicking mutations (S→D or S→E) for functional studies

• Temporal dynamics:

  • Phosphorylation states change rapidly in response to DNA damage

  • Time-course experiments with synchronized cultures are essential

  • Consider using phosphatase inhibitors during extraction to preserve modifications

• Detection sensitivity:

  • Often only a small fraction of the protein is phosphorylated

  • Enrichment strategies such as phospho-peptide enrichment prior to mass spectrometry

  • Use Phos-tag™ gels for improved separation of phosphorylated species

• Contextual dependencies:

  • Phosphorylation may require specific DNA structures or damage types

  • Test multiple damage induction methods (MMS, IR, HU, etc.)

  • Consider chromatin context by combining with nuclease digestion studies

A methodological approach combining phospho-specific antibodies with domain-specific RTT107 antibodies can help elucidate how phosphorylation states modulate the function of RTT107 complexes in genome maintenance.

How should researchers interpret data from RTT107 chromatin association studies?

When analyzing RTT107 chromatin association data, researchers should consider several important factors:

• Distinguish H2A-dependent from H2A-independent functions:

  • The rtt107-K887M mutation reduces RTT107 recruitment to phosphorylated H2A but does not result in an LOH phenotype

  • This suggests that some RTT107 functions in preventing LOH are independent of its H2A-binding capability

  • Compare chromatin association patterns between wild-type RTT107 and the K887M mutant

• Consider context-dependent recruitment:

  • RTT107 associates with different genomic regions depending on its binding partners

  • With Slx4, it contributes to rDNA stability

  • With Rad55, it prevents crossovers and LOH

  • Domain-specific antibodies can help distinguish different recruitment modes

• Analyze temporal dynamics:

  • RTT107 association with chromatin changes throughout S phase

  • Its role in supporting replication progression suggests transient interactions with replisomes

  • Time-course experiments during synchronized S phase are essential

• Examine co-localization patterns:

  • RTT107 co-localizes with replisome components including Pol2 and Mcm6

  • Sequential ChIP can determine whether multiple partners simultaneously associate

  • Correlation analysis between RTT107 binding and replication timing can reveal functional connections

These considerations can help researchers interpret chromatin association data in the context of RTT107's multiple functions in genome maintenance.

How can researchers resolve discrepancies in RTT107 functional studies across different model systems?

When faced with discrepancies in RTT107 functional studies across different models, researchers should consider several methodological approaches:

• Protein conservation analysis:

  • RTT107 is conserved across species but may have evolved different functional emphases

  • Domain-specific antibodies can help identify which functions are conserved

  • Complementation studies with orthologs can determine functional equivalence

• Context-dependent activity:

  • RTT107 functions differently depending on the genomic context

  • Its role in preventing genome instability differs between regular chromosomal regions and specialized regions like rDNA

  • Genome-wide versus locus-specific approaches should be compared

• Interaction network mapping:

  • RTT107 partners may vary between models

  • Systematic co-immunoprecipitation studies followed by mass spectrometry can identify model-specific interactors

  • Network analysis can reveal conserved versus divergent pathways

• Phenotypic analysis hierarchy:

  • Establish which phenotypes are primary versus secondary consequences of RTT107 loss

  • Acute depletion (e.g., auxin-inducible degron) versus genetic knockout can distinguish immediate from adaptive effects

  • Time-course studies can determine the sequence of events following RTT107 disruption

Through these approaches, researchers can build a more comprehensive understanding of RTT107 function that accounts for both conserved and context-specific aspects of its role in genome maintenance.

What are the optimal conditions for immunoprecipitating different RTT107 complexes?

Different RTT107 complexes may require specific optimization strategies for efficient immunoprecipitation:

Key optimization steps include:

• Test multiple antibody binding conditions (temperature, time, buffer composition)

• Determine optimal cell lysis methods for each complex (mechanical, detergent-based, enzymatic)

• Evaluate whether crosslinking improves complex stability and detection

• Consider differential centrifugation to separate chromatin-bound from soluble complexes

Research demonstrates that some RTT107 interactions, such as with Slx4 and Mms22, are stable in both untreated and MMS-treated conditions , while others may be condition-specific or depend on post-translational modifications.

How can researchers troubleshoot failed RTT107 antibody experiments?

When RTT107 antibody experiments fail to yield expected results, researchers should consider a systematic troubleshooting approach:

• Antibody validation issues:

  • Test antibody reactivity against recombinant RTT107 protein

  • Verify specificity using rtt107Δ strains as negative controls

  • Epitope mapping to ensure the recognition site is accessible in experimental conditions

  • Consider testing multiple antibodies targeting different regions

• Complex stability challenges:

  • RTT107 forms distinct complexes that may require different extraction conditions

  • Test a matrix of buffer compositions varying salt, detergents, and pH

  • Consider crosslinking to stabilize transient interactions

  • Add protease and phosphatase inhibitors to preserve modification states

• Technical optimization:

  • Adjust antibody concentrations and incubation times

  • Optimize wash conditions to balance specificity and sensitivity

  • Consider protein A versus protein G beads based on antibody isotype

  • For challenging interactions, try proximity labeling approaches (BioID, APEX)

• Experimental design reconsideration:

  • RTT107 functions can be context-dependent (e.g., H2A-binding versus LOH prevention)

  • Some interactions may be cell cycle-phase specific

  • Consider whether specific DNA damage or replication stress conditions are needed

  • Test detection in both soluble nuclear extract and chromatin fractions

By systematically addressing these potential issues, researchers can improve the success rate of RTT107 antibody experiments and generate more reliable data.